L.KorkinaO.TengX.et al (2008)
D., Leone, L., Pedata, M., Meli, R., & Calignano, A
Intermedin1-53 enhances angiogenesis and attenuates adverse remodeling following myocardial infarction by activating AMP-activated protein kinase
The incidence is relatively low, affecting less than five percent of patients with pre-existing retinopathy, but regular ophthalmologic monitoring is recommended for patients with diabetes-related eye disease
Symptoms include metabolic acidosis, Central Nervous System depression, and respiratory distress
Instructions This information is intended for individuals who have been prescribed Glutathione Patches by their Alan Health provider